Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Advanced Non-Small Cell Lung Cancer
Clinical trial register · Italy

Advanced Non-Small Cell Lung Cancer Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6812 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:19 UTC
6812
Studies in scope
all four open statuses
4098
Recruiting now
open to new participants
1015
Lead sponsors
across recruiting studies
Top sites
Aviano 6 Milan 5 Meldola 4 Bari 3 Brescia 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Advanced Non-Small Cell Lung Cancer trials in Italy

8 of 6812 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Naples, Misterbianco, Meldola, Milan, Fano, Aviano, Roma, Brescia
2026-01-06
Recruiting
ArriVent BioPharma, Inc.
Phase 3
480
Aviano, Milan
2025-12-17
Active, closed
ArriVent BioPharma, Inc.
Phase 3
398
Bari, Milan, Rozzano, Aviano, Roma, Meldola
2023-06-01
Active, closed
Gilead Sciences
Phase 2
400
Meldola, Milan, Padova, Pesaro, Rome
2023-02-21
Active, closed
ArriVent BioPharma, Inc.
Phase 1
160
Medolla
2022-06-30
Recruiting
Bayer
Phase 1/2
430
Naples, Parma, Aviano, Rome, Milan, Rozzano, Orbassano, Verona
2021-10-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Alessandria, Avellino, Aviano, Bari, Brescia, Candiolo, Catania, Florence
2021-02-23
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Aviano, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Meldola
2020-12-02
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-italy/condition/advanced-non-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,812 studies in total at the last sync on 20 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies listing the condition Advanced Non-Small Cell Lung Cancer.

How many Advanced Non-Small Cell Lung Cancer trials are recruiting in Italy?

4 of the 8 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Advanced Non-Small Cell Lung Cancer), 8 studies
PhaseStudiesRecruitingShare
Phase 34250%
Phase 11012.5%
Phase 1/21112.5%
Phase 21012.5%
Phase 2/31112.5%

Most active sponsors

Lead sponsors with the most studies (Advanced Non-Small Cell Lung Cancer)
Lead sponsorStudiesRecruiting
ArriVent BioPharma, Inc.31
Mirati Therapeutics Inc.21
Bayer11
Gilead Sciences10
Pfizer11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.